AI Engines For more Details: Perplexityβ Kagi Labsβ Youβ
Anaphylaxis Risk: Lupin allergy is relatively common, particularly in individuals with peanut or soy allergies. Consumption of lupin or lupin-derived products can trigger severe allergic reactions, including anaphylaxis, in sensitive individuals. Those with lupin allergies should avoid lupin-containing foods and products, including lupin kernel fiber.
Toxicity Concerns: Raw or improperly processed lupin seeds contain alkaloids and other compounds that can be toxic to humans if consumed in large quantities. To mitigate this risk, lupin seeds must undergo appropriate processing methods, such as soaking, boiling, or fermentation, to reduce the levels of toxic compounds and make them safe for consumption. It's essential to follow recommended preparation methods and guidelines when incorporating lupin kernel fiber into the diet to ensure safety.
bluebonnet,Anaphylaxis Risk
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Increases |
genus | Pediococcus | Increases |
species | Bacteroides uniformis | Increases |
species | Bifidobacterium adolescentis | Increases |
species | Bifidobacterium animalis | Increases |
species | Bifidobacterium bifidum | Increases |
species | Bifidobacterium breve | Increases |
species | Bifidobacterium catenulatum | Increases |
species | Bifidobacterium longum | Increases |
species | Bifidobacterium pseudocatenulatum | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
Taxonomy | Rank | Effect | Citations | Notation |
---|---|---|---|---|
[Eubacterium] cellulosolvens | species | Decreases | πΆ Source Study | |
[Lactobacillus] rogosae | species | Increases | πΆ Source Study | |
Acidaminococcaceae | family | Increases | πͺ Source Study | |
Agathobacter | genus | Increases | πͺ Source Study | |
Agathobacter rectalis | species | Increases | π Source Study | |
Atopobiaceae | family | Increases | πͺ Source Study | |
Atopobium | genus | Increases | π Source Study | |
Atopobium deltae | species | Increases | πΆ Source Study | |
Atopobium fossor | species | Increases | πΆ Source Study | |
Atopobium massiliense | species | Increases | πΆ Source Study | |
Atopobium minutum | species | Increases | πΆ Source Study | |
Bacteroides | genus | Increases | π Source Study | |
Bacteroides acidifaciens | species | Increases | πΆ Source Study | |
Bacteroides bouchesdurhonensis | QSV445 | Increases | πΆ Source Study | |
Bacteroides caccae | species | Increases | πΆ Source Study |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive β X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.2 | -0.2 | |
Acne | 1.6 | 1.5 | 0.07 |
ADHD | 1.3 | 3.5 | -1.69 |
Age-Related Macular Degeneration and Glaucoma | 1 | 0.6 | 0.67 |
Allergic Rhinitis (Hay Fever) | 3.2 | 3 | 0.07 |
Allergies | 6.8 | 3.2 | 1.13 |
Allergy to milk products | 2.5 | 2.7 | -0.08 |
Alopecia (Hair Loss) | 2.4 | 0.5 | 3.8 |
Alzheimer's disease | 6.7 | 6.2 | 0.08 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2 | 3.7 | -0.85 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription
All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]